Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)
Clinical trial NCT00822237 · COMPLETED
Trial details
- NCT number
- NCT00822237
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 598
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.